ArticleFrontiers in psychiatry2025
Prevalence and associated factors of depression and anxiety among patients with melasma: a cross-sectional study in China.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Q-Switched 1064 nm Fractional Laser with Intradermal Tranexamic Acid for Melasma: A Retrospective Propensity Score-Matched Study.Clinical, cosmetic and investigational dermatology · 2026Article
- Knowledge, attitudes, and practices regarding melasma among female patients.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Melasma is a common acquired skin hyperpigmentation disorder characterized by light to dark brown macules and patches, predominantly on the face. Due to its visible nature, the condition often imposes substantial psychological and emotional burdens on affected individuals. Depression and anxiety are common conditions that occur in patients suffering from melasma; however, comprehensive data regarding their prevalence and associated factors remain scarce. This cross-sectional observational study aimed to assess the prevalence of depression and anxiety in patients with melasma and identify potential associated factors. Methods: A total of 264 melasma patients were recruited for the study between July 2023 and May 2024. Depression and anxiety were assessed using the Self-rating Depression Scale (SDS) and the Self-rating Anxiety Scale (SAS), respectively. Univariate and multivariate logistic regression analyses were conducted to determine variables associated with depression and anxiety among patients with melasma. Results: The study revealed a prevalence of 33.3% (95% CI: 27.610-39.057) for depression and 21.6% (95% CI: 16.595-26.587) for anxiety among melasma patients. Age ≥ 45 years, high BMI and poor quality of life were identified as factors independently associated with depression in patients with melasma. Poor sleep quality was found to be an independently relative factor for anxiety among patients with melasma. Conclusions: The prevalence of depression and anxiety was higher among patients with melasma. Depression was negatively correlated with the older but positively correlated with high BMI and poor quality of life. Anxiety was positively associated with poor sleep quality. On the basis of these findings, the present study suggests that routine screening for depression and anxiety should be conducted in patients with melasma to facilitate early intervention strategies. Such targeted approaches may not only enhance treatment outcomes but also significantly improve patients' overall quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.